{"id":"W2595403257","doi":"10.1007/s00280-017-3260-6","title":"A phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma","year":2017,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Oncolytics Biotech","keywords":"Chills; Medicine; Carboplatin; Internal medicine; Melanoma; Nausea; Oncology; Adverse effect; Paclitaxel; Phases of clinical research; Chemotherapy; Immunotherapy; Gastroenterology; myalgia; Cancer; Immunology; Cisplatin; Cancer research","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001442647,0.0001447514,0.0002242952,0.00005024563,0.000170648,0.00001140364,0.0001244108,0.00006706423,0.00001731716],"category_scores_gemma":[0.000006589249,0.0001135426,0.00001507633,0.00004114321,0.0001788131,0.0000108933,0.00004053387,0.00006739879,2.684691e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001626373,"about_ca_system_score_gemma":0.00006538527,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005022791,"about_ca_topic_score_gemma":0.0004742706,"domain_scores_codex":[0.9991744,0.00005603585,0.0001495739,0.0003381128,0.00008769565,0.0001941855],"domain_scores_gemma":[0.9994228,0.00001743489,0.000168818,0.0002116486,0.0001234405,0.00005588333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.06206559,0.003146901,0.07909346,0.00007797705,0.0003500168,0.000003822504,0.001167563,0.00002582358,0.7545081,0.000005795939,0.00006616395,0.09948881],"study_design_scores_gemma":[0.1109886,0.1274231,0.0271529,0.00003942432,0.00007076388,0.000001970167,0.0002335023,0.0002134143,0.7325177,0.00004605926,0.001002069,0.0003104257],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997701,0.0007447204,0.00002696932,0.0001888447,0.00004132004,0.001226372,0.00004557969,0.000003141918,0.00002199765],"genre_scores_gemma":[0.9987243,0.0005457893,0.0001065043,0.0001558965,0.00003585258,0.0003279382,0.0000264817,0.00002365343,0.00005360479],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1242762,"threshold_uncertainty_score":0.4630134,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01482268013146391,"score_gpt":0.3479693058060301,"score_spread":0.3331466256745662,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}